Effector T cells require fatty acid metabolism during murine graft-versus-host disease

Blood

Volumn 122, Issue 18, 2013, Pages 3230-3237

  Byersdorfer, Craig A ^a   Tkachev, Victor ^a   Opipari, Anthony W ^a   Goodell, Stefanie ^a   Swanson, Jacob ^a   Sandquist, Stacy ^a   Glick, Gary D ^b   Ferrara, James L M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CESIUM 137; FATTY ACID; IMMUNOSUPPRESSIVE AGENT; CARNITINE PALMITOYLTRANSFERASE; ENZYME INHIBITOR; EPOXIDE; ETOMOXIR; PPARGC1A PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

AEROBIC METABOLISM; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOREACTIVE T CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; EX VIVO STUDY; FATTY ACID METABOLISM; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; ANIMAL; BONE MARROW TRANSPLANTATION; C3H MOUSE; C57BL MOUSE; DBA MOUSE; DRUG EFFECTS; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; OXIDATION REDUCTION REACTION; PROCEDURES; T LYMPHOCYTE SUBPOPULATION; DRUG EFFECT; METHODOLOGY;

ANIMALS; BLOTTING, WESTERN; BONE MARROW TRANSPLANTATION; CARNITINE O-PALMITOYLTRANSFERASE; ENZYME INHIBITORS; EPOXY COMPOUNDS; FATTY ACIDS; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; OXIDATION-REDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; TRANSCRIPTION FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84891607730     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-04-495515     Document Type: Article

References (31)

1. Badovinac VP, Haring JS, Harty JT. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8(1) T cell response to infection. Immunity. 2007;26(6):827-841.
2. Yoon H, Kim TS, Braciale TJ. The cell cycle time of CD81 T cells responding in vivo is controlled by the type of antigenic stimulus. PLoS ONE. 2010; 5(11):e15423.
3. Kaech SM, Cui W. Transcriptional control of effector and memory CD81 T cell differentiation. Nat Rev Immunol. 2012;12(11):749-761.
4. Zhang N, Bevan MJ. CD8(1) T cells: foot soldiers of the immune system. Immunity. 2011;35(2):161-168.
5. Lanzavecchia A, Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol. 2002;2(12): 982-987.
6. Jacobs SR, Herman CE, Maciver NJ, et al. Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol. 2008;180(7): 4476-4486.
7. Michalek RD, Gerriets VA, Jacobs SR, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD41 T cell subsets. J Immunol. 2011; 186(6):3299-3303.
8. Fox CJ, Hammerman PS, Thompson CB. Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol. 2005;5(11):844-852.
9. Pearce EL. Metabolism in T cell activation and differentiation. Curr Opin Immunol. 2010;22(3): 314-320.
10. Frauwirth KA, Riley JL, Harris MH, et al. The CD28 signaling pathway regulates glucose metabolism. Immunity. 2002;16(6):769-777.
11. Pearce EL, Walsh MC, Cejas PJ, et al. Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 2009;460(7251):103-107.
12. Sena LA, Li S, Jairaman A, et al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity. 2013;38(2):225-236.
13. van der Windt GJ, Everts B, Chang CH, et al. Mitochondrial respiratory capacity is a critical regulator of CD81 T cell memory development. Immunity. 2012;36(1):68-78.
14. Wang R, Dillon CP, Shi LZ, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011; 35(6):871-882.
15. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674): 1550-1561.
16. Gatza E, Wahl DR, Opipari AW, et al. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med. 2011;3(67):67ra8.
17. Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 1996;88(8):3230-3239.
18. Magee JA, Ikenoue T, Nakada D, Lee JY, Guan KL, Morrison SJ. Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression. Cell Stem Cell. 2012;11(3):415-428.
19. Keller P, Petrie JT, De Rose P, et al. Fat-specific protein 27 regulates storage of triacylglycerol. J Biol Chem. 2008;283(21):14355-14365.
20. Harris DM, Li L, Chen M, Lagunero FT, Go VL, Boros LG. Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75. Metabolomics. 2012;8(2):201-210.
21. 13C isotopomer distribution analysis of lactate, glutamate and glucose. Food Chem Toxicol. 2011;49(11):2968-2974.
22. Carr EL, Kelman A, Wu GS, et al. Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J Immunol. 2010;185(2):1037-1044.
23. Jensen KK, Previs SF, Zhu L, et al. Demonstration of diet-induced decoupling of fatty acid and cholesterol synthesis by combining gene expression array and 2H2O quantification. Am J Physiol Endocrinol Metab. 2012;302(2):E209-E217.
24. Lehman JJ, Boudina S, Banke NH, et al. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol. 2008;295(1):H185-H196.
25. Leone TC, Lehman JJ, Finck BN, et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005;3(4):e101.
26. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol. 2000;20(5):1868-1876.
27. Jones RG, Thompson CB. Revving the engine: signal transduction fuels T cell activation. Immunity. 2007;27(2):173-178.
28. Samudio I, Harmancey R, Fiegl M, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest. 2010;120(1):142-156.
29. Gerriets VA, Rathmell JC. Metabolic pathways in T cell fate and function. Trends Immunol. 2012; 33(4):168-173.
30. de Bueger M, Bakker A, Van Rood JJ, Van der Woude F, Goulmy E. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol. 1992;149(5):1788-1794.
31. Eden PA, Christianson GJ, Fontaine P, Wettstein PJ, Perreault C, Roopenian DC. Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus. J Immunol. 1999; 162(8):4502-4510.